Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the Price
TUESDAY, Aug. 27, 2024 (HealthDay News) — Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says it will now offer the medication in single-dose vials at half the price currently available to consumers. The new 2.5 milligram (mg) and 5 mg weekly dose vials differ fromContinue Reading